These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

731 related items for PubMed ID: 23150224

  • 1. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
    Beaumont E, Patient R, Hourioux C, Dimier-Poisson I, Roingeard P.
    Hepatology; 2013 Apr; 57(4):1303-13. PubMed ID: 23150224
    [Abstract] [Full Text] [Related]

  • 2. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT, Boo I, Drummer HE, Netter HJ.
    Antivir Ther; 2007 Apr; 12(4):477-87. PubMed ID: 17668556
    [Abstract] [Full Text] [Related]

  • 3. Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies.
    Patient R, Hourioux C, Vaudin P, Pagès JC, Roingeard P.
    N Biotechnol; 2009 Apr; 25(4):226-34. PubMed ID: 19356608
    [Abstract] [Full Text] [Related]

  • 4. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Wei S, Lei Y, Yang J, Wang X, Shu F, Wei X, Lin F, Li B, Cui Y, Zhang H, Wei S.
    Vaccine; 2018 Apr 19; 36(17):2273-2281. PubMed ID: 29576303
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
    Johnson J, Freedman H, Logan M, Wong JAJ, Hockman D, Chen C, He J, Beard MR, Eyre NS, Baumert TF, Tyrrell DL, Law JLM, Houghton M.
    J Virol; 2019 Nov 15; 93(22):. PubMed ID: 31462563
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Incorporation of apolipoprotein E into HBV-HCV subviral envelope particles to improve the hepatitis vaccine strategy.
    Gomez-Escobar E, Burlaud-Gaillard J, Visdeloup C, Ribeiro E Silva A, Coutant P, Roingeard P, Beaumont E.
    Sci Rep; 2021 Nov 08; 11(1):21856. PubMed ID: 34750487
    [Abstract] [Full Text] [Related]

  • 9. Expression, purification and immunogenic characterization of hepatitis C virus recombinant E1E2 protein expressed by Pichia pastoris yeast.
    Cai W, Su L, Liao Q, Ye L, Wu Y, Wu Z, She Y.
    Antiviral Res; 2010 Oct 08; 88(1):80-5. PubMed ID: 20691736
    [Abstract] [Full Text] [Related]

  • 10. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM, Logan M, Wong J, Kundu J, Hockman D, Landi A, Chen C, Crawford K, Wininger M, Johnson J, Mesa Prince C, Dudek E, Mehta N, Tyrrell DL, Houghton M.
    J Virol; 2018 Jun 01; 92(11):. PubMed ID: 29540595
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.
    Siler CA, McGettigan JP, Dietzschold B, Herrine SK, Dubuisson J, Pomerantz RJ, Schnell MJ.
    Virology; 2002 Jan 05; 292(1):24-34. PubMed ID: 11878905
    [Abstract] [Full Text] [Related]

  • 14. Mixing particles from various HCV genotypes increases the HBV-HCV vaccine ability to elicit broadly cross-neutralizing antibodies.
    Beaumont E, Joël Clément B, Guérin V, Chopin L, Roch E, Gomez-Escobar E, Roingeard P.
    Liver Int; 2020 Aug 05; 40(8):1865-1871. PubMed ID: 32458507
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.
    Czarnota A, Tyborowska J, Peszyńska-Sularz G, Gromadzka B, Bieńkowska-Szewczyk K, Grzyb K.
    Microb Cell Fact; 2016 Apr 13; 15():62. PubMed ID: 27075377
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles.
    Kachko A, Kochneva G, Sivolobova G, Grazhdantseva A, Lupan T, Zubkova I, Wells F, Merchlinsky M, Williams O, Watanabe H, Ivanova A, Shvalov A, Loktev V, Netesov S, Major ME.
    Vaccine; 2011 Dec 09; 30(1):69-77. PubMed ID: 22041300
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.